SARS-CoV-2 membrane glycoprotein Blocking Peptide
Catalog no. P-SARS-COV2-M · Research Use Only
$155 per 250 µg. Ships within 2–3 business days from the U.S.
P-SARS-COV2-M — affinity-purified Rabbit antibody against COVID19 membrane glycoprotein. Validated for Immunodepletion, Immunocompetition.
Specifications
| Catalog number | P-SARS-COV2-M |
|---|---|
| Target | COVID19 membrane glycoprotein |
| Applications | Immunodepletion, Immunocompetition |
| Conjugate | Unconjugated |
| Immunogen | Synthetic peptide taken from unique amino acid sequence on membrane glycoprotein [Severe acute respiratory syndrome coronavirus 2]. |
| Size | 250 µg |
| Storage | -20°C |
About this target
SARS-CoV-2 membrane glycoprotein Blocking Peptide is the antigenic blocking peptide for the COVID19 membrane glycoprotein antibody SARS-COV2-M-101AP. Pre-incubating the antibody with the peptide competes away specific binding, which helps confirm that a signal comes from the intended target. Supplied at 250 µg, for research use only.
Documents
Related products
- SARS-CoV-2 membrane glycoprotein Positive Control (PC-SARS-COV2-M)
- SARS-CoV-2 membrane glycoprotein Antibody (SARS-COV2-M-101AP)
- SARS-CoV-2 membrane glycoprotein Antibody BIOTIN (SARS-COV2-M-BIOTIN)
- SARS-CoV-2 membrane glycoprotein Antibody FITC (SARS-COV2-M-FITC)
- SARS-CoV-2 Membrane Glycoprotein Recombinant Protein (SARS-COV2-M-PROT)
FabGennix International, Inc., 9191 Kyser Way, Frisco, TX 75033. For research use only. Not for diagnostic or therapeutic use.